Investigation of 1, 3, 4 Oxadiazole Derivative in PTZ-Induced Neurodegeneration: A Simulation and Molecular Approach

References

• Varvel NH, Jiang J, Dingledine R. Candidate drug targets for prevention or modification of epilepsy. Annu Rev Pharmacol Toxicol. 2015;55:229–247. doi:10.1146/annurev-pharmtox-010814-124607
   PubMed Web of Science ®Google Scholar
• Lees G, Leach MJ. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res. 1993;612(1):190–199. doi:10.1016/0006-8993(93)91660-K
   PubMed Web of Science ®Google Scholar
• Rosenow F, Strzelczyk A. Behavior. Individualized epilepsy management: medicines, surgery, and beyond. Epilepsy Behav. 2019;91:1–3. doi:10.1016/j.yebeh.2018.09.045
   PubMed Web of Science ®Google Scholar
• Rashidian A, Kazemi F, Mehrzadi S, et al. Anticonvulsant effects of aerial parts of Verbena officinalis extract in mice: involvement of benzodiazepine and opioid receptors. J Evid Based Complementary Altern Med. 2017;22(4):632–636. doi:10.1177/2156587217709930
   PubMedGoogle Scholar
• Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42:8–12.
   PubMed Web of Science ®Google Scholar
• Ochoa JG, Kilgo WA. The role of benzodiazepines in the treatment of epilepsy. Curr Treat Options Neurol. 2016;18(4):18. doi:10.1007/s11940-016-0401-x
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamagata KJJ. Pentylenetetrazole-induced kindling mouse model. J Vis Exp. 2018;136:e56573.
   Google Scholar
• Hoffman E, Warren E. Flumazenil: a benzodiazepine antagonist. Clin Pharm. 1993;12(9):641–656; quiz 699–701.
   PubMedGoogle Scholar
• Votey SR, Bosse GM, Bayer MJ, Hoffman JR. Flumazenil: a new benzodiazepine antagonist. Ann Emerg Med. 1991;20(2):181–188. doi:10.1016/S0196-0644(05)81219-3
   PubMed Web of Science ®Google Scholar
• Faheem M, Khan A-U, Nadeem H, Ali F. Computational and pharmacological evaluation of heterocyclic 1, 3, 4-oxadiazole and pyrazoles novel derivatives for toxicity assessment, tumour inhibition, antioxidant, analgesic and anti-inflammatory actions. Farmacia. 2018;66(5):909–919. doi:10.31925/farmacia.2018.5.24
   Web of Science ®Google Scholar
• Faheem M, Ali SH, Khan AW, et al. 1, 3, 4-Oxadiazole derivative attenuates chronic constriction injury induced neuropathic pain: a computational, behavioral, and molecular approach. Brain Sci. 2020;10(10):731. doi:10.3390/brainsci10100731
   PubMed Web of Science ®Google Scholar
• Malghani Z, Khan A-U, Faheem M, et al. Molecular docking, antioxidant, anticancer and antileishmanial effects of newly synthesized quinoline derivatives. Anticancer Agents Med Chem. 2020;20(13):1516–1529. doi:10.2174/1871520620666200516145117
   PubMed Web of Science ®Google Scholar
• Anwar T, Nadeem H, Sarwar S, et al. Investigation of antioxidant and anti‐nociceptive potential of isoxazolone, pyrazolone derivatives, and their molecular docking studies. Drug Dev Res. 2020;81(7):893–903. doi:10.1002/ddr.21711
   PubMed Web of Science ®Google Scholar
• Ahmad S, Khan AU, Faheem M, et al. Computational and pharmacological evaluation of stevioside derivatives for antinociceptive and antiinflammatory potential. Trop J Pharm Res. 2020;19(8):1677–1684. doi:10.4314/tjpr.v19i8.16
   Web of Science ®Google Scholar
• Ivanova L, Tammiku-Taul J, García-Sosa AT, Sidorova Y, Saarma M, Karelson M. Molecular dynamics simulations of the interactions between glial cell line-derived neurotrophic factor family receptor GFRα1 and small-molecule ligands. ACS Omega. 2018;3(9):11407–11414. doi:10.1021/acsomega.8b01524
   PubMed Web of Science ®Google Scholar
• Hou H, Wang Y, Li C, Wang J, Cao Y. Dipeptidyl peptidase-4 is a target protein of epigallocatechin-3-gallate. Biomed Res Int. 2020;2020:54.
   Web of Science ®Google Scholar
• Eid EE, Azam F, Hassan M, Taban IM, Halim MA, Transduction S. Zerumbone binding to estrogen receptors: an in-silico investigation. J Recept Signal Transduct Res. 2018;38(4):342–351. doi:10.1080/10799893.2018.1531886
   PubMed Web of Science ®Google Scholar
• Khan AW, Khan AU, Ahmed T. Anticonvulsant, anxiolytic, and sedative activities of Verbena officinalis. Front Pharmacol. 2016;7:499. doi:10.3389/fphar.2016.00499
   PubMed Web of Science ®Google Scholar
• Nejad SR, Motevalian M, Fatemi I, Shojaii A. Anticonvulsant effects of the hydroalcoholic extract of Alpinia officinarum rhizomes in mice: involvement of benzodiazepine and opioid receptors. J Epilepsy Res. 2017;7(1):33. doi:10.14581/jer.17006
   PubMedGoogle Scholar
• Hosseinzadeh H, Parvardeh S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine. 2004;11(1):56–64. doi:10.1078/0944-7113-00376
   PubMed Web of Science ®Google Scholar
• Iqbal S, Shah FA, Naeem K, et al. Succinamide derivatives ameliorate neuroinflammation and oxidative stress in scopolamine-induced neurodegeneration. Biomolecules. 2020;10(3):443. doi:10.3390/biom10030443
   PubMed Web of Science ®Google Scholar
• Kumar KS, Hsieh HW, Wang S-Y. Anti-inflammatory effect of lucidone in mice via inhibition of NF-κB/MAP kinase pathway. Int Immunopharmacol. 2010;10(4):385–392. doi:10.1016/j.intimp.2009.12.013
   PubMed Web of Science ®Google Scholar
• Imran M, Al Kury LT, Nadeem H, et al. Benzimidazole containing acetamide derivatives attenuate neuroinflammation and oxidative stress in ethanol-induced neurodegeneration. Biomolecules. 2020;10(1):108. doi:10.3390/biom10010108
   PubMed Web of Science ®Google Scholar
• Al Kury LT, Zeb A, Abidin ZU, et al. Neuroprotective effects of melatonin and celecoxib against ethanol-induced neurodegeneration: a computational and pharmacological approach. Drug Des DevelTher. 2019;13:2715.
   PubMed Web of Science ®Google Scholar
• Mohsin Alvi A, Tariq Al Kury L, Umar Ijaz M, et al. Post-treatment of synthetic polyphenolic 1, 3, 4 oxadiazole compound A3, attenuated ischemic stroke-induced neuroinflammation and neurodegeneration. Biomolecules. 2020;10(6):816. doi:10.3390/biom10060816
   PubMed Web of Science ®Google Scholar
• Ali A, Shah FA, Zeb A, et al. NF-κB inhibitors attenuate MCAO induced neurodegeneration and oxidative stress—a reprofiling approach. Front Mol Neurosci. 2020;13:33. doi:10.3389/fnmol.2020.00033
   PubMed Web of Science ®Google Scholar
• Komirishetty P, Areti A, Gogoi R, Sistla R, Kumar A. Combination strategy of PARP inhibitor with antioxidant prevent bioenergetic deficits and inflammatory changes in CCI-induced neuropathy. Neuropharmacology. 2017;113:137–147. doi:10.1016/j.neuropharm.2016.09.027
   PubMed Web of Science ®Google Scholar
• Van Erum J, Van Dam D, De Deyn PP. PTZ-induced seizures in mice require a revised Racine scale. Epilepsy Behav. 2019;95:51–55. doi:10.1016/j.yebeh.2019.02.029
   PubMed Web of Science ®Google Scholar
• Viswanatha GL, Shylaja H, Kishore DV, Venkataranganna MV, Prasad NBL. Acteoside isolated from colebrookea oppositifolia smith attenuates epilepsy in mice via modulation of gamma-aminobutyric acid pathways. Neurotox Res. 2020;38(4):1010–1023. doi:10.1007/s12640-020-00267-0
   PubMedGoogle Scholar
• Alvi AM, Al Kury LT, Alattar A, et al. Carveol attenuates seizure severity and neuroinflammation in pentylenetetrazole-kindled epileptic rats by regulating the Nrf2 signaling pathway. Oxid Med Cell Longev. 2021;2021:452.
   Web of Science ®Google Scholar
• Cramer JA, Mintzer S, Wheless J, Mattson RH. Adverse effects of antiepileptic drugs: a brief overview of important issues. Expert Rev Neurother. 2010;10(6):885–891. doi:10.1586/ern.10.71
   PubMed Web of Science ®Google Scholar
• Sahu M, Siddiqui N, Naim MJ, et al. Design, synthesis, and docking study of pyrimidine–triazine hybrids for GABA estimation in animal epilepsy models. Arch Pharm. 2017;350(9):1700146. doi:10.1002/ardp.201700146
   Web of Science ®Google Scholar
• Fabjan J, Koniuszewski F, Schaar B, Ernst M. Structure-guided computational methods predict multiple distinct binding modes for pyrazoloquinolinones in GABAA receptors. Front Neurosci. 2021;14:1452. doi:10.3389/fnins.2020.611953
   Web of Science ®Google Scholar
• Hollingsworth SA, Dror RO. Molecular dynamics simulation for all. Neuron. 2018;99(6):1129–1143. doi:10.1016/j.neuron.2018.08.011
   PubMed Web of Science ®Google Scholar
• Karplus M, McCammon JA. Molecular dynamics simulations of biomolecules. Nat Struct Biol. 2002;9(9):646–652. doi:10.1038/nsb0902-646
   PubMedGoogle Scholar
• McCammon JA, Gelin BR, Karplus M. Dynamics of folded proteins. Nature. 1977;267(5612):585–590. doi:10.1038/267585a0
   PubMed Web of Science ®Google Scholar
• Levitt M, Lifson S. Refinement of protein conformations using a macromolecular energy minimization procedure. J Mol Biol. 1969;46(2):269–279. doi:10.1016/0022-2836(69)90421-5
   PubMed Web of Science ®Google Scholar
• Dawe GB, Musgaard M, Aurousseau MR, et al. Distinct structural pathways coordinate the activation of AMPA receptor-auxiliary subunit complexes. Neuron. 2016;89(6):1264–1276. doi:10.1016/j.neuron.2016.01.038
   PubMed Web of Science ®Google Scholar
• McCorvy JD, Butler KV, Kelly B, et al. Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs. Nat Chem Biol. 2018;14(2):126–134. doi:10.1038/nchembio.2527
   PubMed Web of Science ®Google Scholar
• Spahn V, Del Vecchio G, Labuz D, et al. A nontoxic pain killer designed by modeling of pathological receptor conformations. Science. 2017;355(6328):966–969. doi:10.1126/science.aai8636
   PubMed Web of Science ®Google Scholar
• Chinnala KM, Shanmugam D, Elsani MM. Antiepileptic activity of Alstonia scholaris Linn. on Mes, Ptz and Strychnine induced convulsions in rats. Int j Pharm Biol Sci. 2016;6(1):207–213.
   Google Scholar
• El-Missiry MA, Othman AI, Amer MA, Sedki M, Ali SM, El-Sherbiny IM. Nanoformulated ellagic acid ameliorates pentylenetetrazol-induced experimental epileptic seizures by modulating oxidative stress, inflammatory cytokines and apoptosis in the brains of male mice. Metab Brain Dis. 2020;35(2):385–399. doi:10.1007/s11011-019-00502-4
   PubMed Web of Science ®Google Scholar
• Temp FR, Marafiga JR, Milanesi LH, et al. Cyclooxygenase-2 inhibitors differentially attenuate pentylenetetrazol-induced seizures and increase of pro-and anti-inflammatory cytokine levels in the cerebral cortex and hippocampus of mice. Eur J Pharmacol. 2017;810:15–25. doi:10.1016/j.ejphar.2017.05.013
   PubMed Web of Science ®Google Scholar
• Yuhas Y, Shulman L, Weizman A, et al. Involvement of tumor necrosis factor alpha and interleukin-1β in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae. Infect Immun. 1999;67(3):1455–1460. doi:10.1128/IAI.67.3.1455-1460.1999
   PubMed Web of Science ®Google Scholar
• Vitaliti G, Pavone P, Marino S, Saporito MAN, Corsello G, Falsaperla R. Molecular mechanism involved in the pathogenesis of early-onset epileptic encephalopathy. Front Mol Neurosci. 2019;12:118. doi:10.3389/fnmol.2019.00118
   PubMed Web of Science ®Google Scholar
• Chao CC, Hu SX, Ehrlich L, Peterson PK. Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun. 1995;9(4):355–365. doi:10.1006/brbi.1995.1033
   PubMed Web of Science ®Google Scholar
• Patel DC, Wallis G, Dahle EJ, et al. Hippocampal TNFα signaling contributes to seizure generation in an infection-induced mouse model of limbic epilepsy. eNeuro. 2017;4(2):ENEURO.0105–17.2017. doi:10.1523/ENEURO.0105-17.2017
   PubMed Web of Science ®Google Scholar
• Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer’s disease. Neurobiol Aging. 2000;21(3):383–421. doi:10.1016/S0197-4580(00)00124-X
   PubMed Web of Science ®Google Scholar
• Eikelenboom P, Bate C, Van Gool W, et al. Neuroinflammation in Alzheimer’s disease and prion disease. Glia. 2002;40(2):232–239. doi:10.1002/glia.10146
   PubMed Web of Science ®Google Scholar
• Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener. 2011;6(1):1–9. doi:10.1186/1750-1326-6-85
   PubMedGoogle Scholar
• Pascual M, Blanco AM, Cauli O, Miñarro J, Guerri C. Intermittent ethanol exposure induces inflammatory brain damage and causes long‐term behavioural alterations in adolescent rats. Eur J Neurosci. 2007;25(2):541–550. doi:10.1111/j.1460-9568.2006.05298.x
   PubMed Web of Science ®Google Scholar
• Zhang J, Li J-C, Song J-L, Cheng Z-Q, Sun J-Z, Jiang C-S. Synthesis and evaluation of coumarin/1, 2, 4-oxadiazole hybrids as selective BChE inhibitors with neuroprotective activity. J Asian Nat Prod Res. 2018;21(11):1090–1103. doi:10.1080/10286020.2018.1492566
   PubMed Web of Science ®Google Scholar
• Biernacki K, Daśko M, Ciupak O, Kubiński K, Rachon J, Demkowicz S. Novel 1, 2, 4-oxadiazole derivatives in drug discovery. Pharmaceuticals. 2020;13(6):111. doi:10.3390/ph13060111
   Web of Science ®Google Scholar
• Mohammadi-Khanaposhtani M, Saeedi M, Zafarghandi NS, et al. Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1, 2, 3-triazole derivatives. Eur J Med Chem. 2015;92:799–806. doi:10.1016/j.ejmech.2015.01.044
   PubMed Web of Science ®Google Scholar
• Mohammadi-Khanaposhtani M, Shabani M, Faizi M, et al. Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1, 2, 4-oxadiazoles as potential anticonvulsant agents. Eur J Med Chem. 2016;112:91–98. doi:10.1016/j.ejmech.2016.01.054
   PubMed Web of Science ®Google Scholar